| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From the National Center for PTSDBehavioral Science Division, Boston VAMC, and Boston University School of Medicine, Boston, Massachusetts.
Address reprint requests to: Todd C. Buckley, PhD, National Center for PTSD (116B-2), VA Boston Healthcare System, 150 South Huntington Avenue, Boston, MA 02131-4817. Email: Todd.Buckley{at}med.va.gov
| ABSTRACT |
|---|
|
|
|---|
METHODS: Meta-analytic data methods were applied to 34 studies that gathered indicators of basal cardiovascular activity including: heart rate (HR), systolic blood pressure, and diastolic blood pressure on subjects diagnosed with PTSD and two types of comparison groups. In total, cardiovascular measures were analyzed for 2670 subjects across all studies.
RESULTS: Results indicate that individuals with a current PTSD diagnosis have higher resting HR relative to both trauma-exposed individuals without a PTSD diagnosis and nontrauma-exposed individuals. The results also suggest that PTSD is associated with elevations in blood pressure; however, the effect sizes were smaller in magnitude than those obtained for heart rate. A subset analysis revealed that the effect sizes for comparisons on basal HR were greatest in studies with the most chronic PTSD samples.
CONCLUSION: The meta-analysis supports previous qualitative reviews, finding a positive association between PTSD and basal cardiovascular activity. The discussion addresses possible mechanisms of action and the health-related implications of these findings.
Key Words: posttraumatic stress disorder cardiovascular heart rate blood pressure
Abbreviations: PTSD = posttraumatic stress disorder; HR = heart rate; RR = respiration rate; EEG = electroencephalograph; SBP = systolic blood pressure; DBP = diastolic blood pressure; CI = confidence interval.
| INTRODUCTION |
|---|
|
|
|---|
Dobbs and Wilson (4) provided the first laboratory-based demonstration of this phenomenon when they examined HR, RR, and EEG responses of World War II and Korean War combat veterans to auditory presentations that simulated combat sounds. Although the majority of the veterans found the protocol too aversive to complete, those who did showed both higher baseline levels of HR and RR and greater magnitude of cardiac response to the auditory stimuli relative to the comparison group of university students. This study showed that humans exposed to strong aversive conditioning events during combat (ie, traumatic stress) produce patterns of autonomic reactivity like those seen in research on fear acquisition with infrahumansa notion that has been increasingly accepted in recent years (5).
The past 2 decades have witnessed a tremendous increase in research examining both phasic and tonic changes in the autonomic profile of individuals exposed to severe trauma, especially those subsequently diagnosed with PTSD (6). A corresponding increase in the precision of physiological measurement has resulted in a large number of high-quality laboratory-based studies that have examined the autonomic responses of patients with PTSD (7, 8).
These studies have used two primary laboratory paradigms. The first, often referred to as the cue-reactivity paradigm, involves assessment of physiological response to narrative descriptions of trauma (9), pictorial representations (7), or auditory representations of traumatic events (10). The second method, the acoustic startle probe paradigm (11), examines physiological responses evoked by loud and unexpected/unpredictable acoustic stimuli. Both paradigms focus on the direction and magnitude of reactivity of various physiological responsesthat is, on phasic changes in physiology on exposure to specific stimuli.
Another important physiological feature of PTSD was identified by Blanchard (12), who noted apparent basal elevations in cardiovascular activity, particularly heart rate, shown by PTSD groups relative to comparison groups during the resting baseline periods of such studies. Blanchard proposed that PTSD might be a risk factor for hypertension or other cardiovascular problems, in light of evidence that links stress-induced cardiovascular reactivity with changes in basal cardiovascular levels (13, 14).
Three hypotheses have been advanced to explain why PTSD may be associated with elevated basal cardiovascular activity. First, elevations at baseline may reflect systemic changes in cardiovascular function that result from repeated cardiovascular responses to stress (13, 14). Indeed, numerous studies show that, relative to traumatized subjects without PTSD, those with PTSD show exaggerated cardiovascular responses to trauma reminiscent cues in laboratory challenge studies (6). It is likely that these cardiovascular responses to trauma cues are mediated by the sympathetic branch of the autonomic nervous system, because individuals diagnosed with PTSD show elevated catecholamine levels, relative to comparison subjects without PTSD, after exposure to stressors (15, 16). Such repeated autonomic reactivity may produce structural and/or functional changes in the cardiovascular system. For example, chronic, stress-related sympathetic activation has been linked to down-regulation of beta-adrenergic receptors in the heart and peripheral vasculature, which increases peripheral vascular resistance and can ultimately lead to an increase in blood pressure (17, 18).
The second hypothesis attributes baseline differences in cardiovascular activity to either emotional priming or apprehension. Priming can occur when exposure to trauma-relevant cues takes place just before physiological assessment and lowers the threshold for subsequent responding. Anticipatory anxiety is a state of arousal shown by participants awaiting exposure to aversive stimuli in cue-reactivity studies (19). Some investigations have used ambulatory monitoring or other procedural maneuvers to reduce the likelihood of either trauma-specific emotional priming or anticipatory anxiety. Findings from these studies are mixed, with some demonstrating elevated basal levels of heart rate and blood pressure in subjects with PTSD, relative to control groups (2022) and others not doing so (2325).
A third hypothesis proposes that the association between PTSD and basal cardiovascular activity is mediated through variables known to have direct effects on cardiovascular health. For example, it is relatively well documented that alcohol consumption of >3 drinks per day is associated with increased blood pressure and heart rate, as well as increased mortality from coronary artery disease and stroke (2628). PTSD is associated with higher rates of alcohol abuse/dependence (29), with especially high rates occurring in some high-risk trauma populations such as Vietnam veterans (30). PTSD also is associated with elevated rates of smoking (31), which is known to adversely affect cardiovascular health. These influences and others like them (eg, lower aerobic fitness) point to ways in which PTSD can have an indirect impact on basal cardiovascular levels.
To date, no meta-analytic examination of baseline cardiovascular indices in persons with PTSD has been conducted to quantify the magnitude of baseline differences. Therefore, we sought to address three questions with this set of meta-analyses. (1) Are observed differences in basal cardiovascular activity found between PTSD and non-PTSD comparison samples statistically reliable? (2) If such differences are reliable, do they vary in relation to chronicity of the disorder? This question aims to addresses the hypothesis that repeated cardiovascular reactions to stress over long periods of time can have an adverse impact on cardiovascular health. (3) Are differences in baseline cardiovascular levels dependent on emotional priming or anticipatory anxiety? This final question allows us to examine whether certain study methodologies result in artificially high basal cardiovascular measurement in PTSD groups because of emotional priming or anticipatory anxiety. Our meta-analysis was not able to address the potential contribution of other specific health habits on effect size outcome, because the individual studies did not provide data on which such information could be coded.
| METHODS |
|---|
|
|
|---|
The 34 studies selected for the meta-analyses had an average sample size of 82 and included 20 laboratory-based cue-reactivity studies, 6 acoustic startle studies, and 8 nonreactivity studies (eg, ambulatory blood pressure studies or medical clinic basal cardiovascular examinations). Because the majority of phasic reactivity studies to date have been conducted with combat veterans, 59% of the studies in our analysis had exclusively male samples. The length of time since trauma for the PTSD groups ranged from a low of 1 month to a high of >20 years. Additional procedural and sample characteristics, as well as effect sizes for individual studies, are summarized in Table 1. All studies had age- and gender-comparable (relative to the PTSD samples) control groups for comparison purposes.
|
| RESULTS |
|---|
|
|
|---|
|
The comparison between the PTSD samples <8 years posttrauma and age-comparable trauma-exposed non-PTSD samples produced statistically significant unweighted (d = 0.24) and weighted effects (d = 0.23, 95% CI = 0.040.43) across 9 studies (409 subjects). The same effect size comparisons for the PTSD samples >12 years posttrauma were larger in magnitude (unweighted d = 0.53, weighted d = 0.39, 95% CI = 0.290.49) and were statistically significant across 17 studies (1802 subjects). The amount of variance in the underlying data for these subset analyses explained by sampling error was 90% and 82% respectively, which suggests sufficient homogeneity of effect size across studies (40).
Similar analyses based on the distinction between PTSD samples along the chronicity continuum were also conducted with age-comparable nontrauma control groups. For the PTSD sample <8 years posttrauma vs. nontrauma control group comparison, the unweighted (d = 0.46) and weighted effects (d = 0.32, 95% CI = 0.070.58) were statistically significant (5 studies with 247 subjects). Repeating this comparison with the PTSD samples >12 years posttrauma revealed a larger weighted effect size (unweighted d = 0.44, weighted d = 0.52, 95% CI = 0.220.82; 6 studies with 178 subjects). The amount of variance in the underlying data for these subset analyses explained by sampling error was 91% and 100% respectively, which suggests sufficient homogeneity of effect size across studies (40).
The third set of analyses controlled for the potential influences of both emotional priming and anticipatory anxiety by using only studies that did not include either PTSD diagnostic assessment or other study-related trauma reminders within the 48 hours preceding the physiological assessment or study procedures involving exposure to trauma-related aversive stimuli after basal measurement. Studies selected for this secondary meta-analysis have been indicated with double asterisks in the Reference section.1 Again, analysis was limited to heart rate data because too few studies with blood pressure measures fit these criteria.
Relative to trauma-exposed non-PTSD samples, those with PTSD continued to show elevated HR in this subset of 7 studies containing 415 subjects (unweighted d = 0.33, weighted d = 0.26, 95% CI for weighted d = 0.060.46). The comparison to the nontrauma-exposed control samples involved 5 studies with 150 subjects and also revealed higher resting HR for the PTSD samples (unweighted d = 0.53, weighted d = 0.60, 95% CI for weighted d = 0.260.93). The amount of variance in these two analyses attributed to sampling error was 70% and 79%, respectively. Again, the corresponding tests of homogeneity were nonsignificant, indicating sufficient homogeneity for a meta-analytic examination (40).
In order to convey the distribution of cardiovascular measures across groups, we have provided a graphical representation of the group mean values for each individual study on the heart rate and blood pressure variables in Figures 1 and 2, respectively. It is important to note that some studies only reported test statistics (eg, F ratios and degrees of freedom), without group mean data for the diagnostic groups in question. Thus, the number of data points that appear in the graphs is slightly lower than the number of data points that comprised the studies which went into the data analysis. The graphs do however, represent the vast majority of the studies and nicely display the shapes of the distributions of data.
|
|
| DISCUSSION |
|---|
|
|
|---|
The second meta-analysis indicates that the effect size is larger for comparisons of basal HR involving the most chronic PTSD samples. Although our analysis does not allow for causal inferences, it is worthy to note that this pattern is consistent with the cardiovascular reactivity hypothesis whereby the association between PTSD and elevated basal cardiovascular activity is a result of cardiovascular adaptation to repeated stress responses over many years.
The results of the third meta-analysis are not entirely consistent with the hypothesis that that PTSD-related elevation in basal cardiovascular activity is attributable to anticipatory anxiety and/or emotional priming that is often present in laboratory studies of cue-reactivity. The HR difference for this subanalysis were of smaller magnitude than for the omnibus analysis but were still consistent with the general finding of higher resting HR for PTSD groups relative to non-PTSD groups. Although we excluded studies that involved exposure to explicit trauma-related threat cues, it is possible that PTSD samples are more reactive to a variety of stressors, which could also influence the baseline measures. Indeed, there is preliminary evidence that PTSD samples may be more reactive to seemingly "neutral" demands (ie, demands without explicit threat cues related to traumatic experiences; Ref. 41).
Most subjects were in the normotensive range, even though the effect size analyses show that the PTSD samples have greater basal blood pressure than the comparison groups. The preponderance of nonpathologic levels is at least partially attributable to selection criteria applied by the individual studies, which typically excluded individuals taking hypertensive medications (eg, beta-adrenergic blocking agents). The likely impact of this medication exclusion is selective enrollment of subjects with the lowest basal levels of both heart rate and blood pressure. This sampling bias complicates interpretation of PTSD-related elevations in basal cardiovascular activity (eg,
5 mm Hg difference in DBP) as a substantive health risk. It is apparent however, that an elevation of 5 mm Hg in DBP in hypertensive populations does constitute a health risk, given literature reviews that conclude that long-term DBP elevations of this magnitude resulted in increased probability of stroke and coronary heart disease in prospectively studied hypertensive samples (42). Furthermore, a recent large-scale study found that PTSD was associated with an increased risk (relative to a comparable group of veterans without PTSD) of myocardial infarction and atrioventricular conduction problems in a cohort of prospectively followed combat veterans (43). For these reasons, the effect of PTSD on basal cardiovascular activity in the hypertensive spectrum is especially worthy of further exploration.
The elevated HR found in PTSD samples is also worthy of further study, given both infrahuman and human research on cardiac reactivity to stress, which shows that repeated phasic increases in cardiac activity and sustained elevated HR as a function of chronic stress can facilitate atherosclerotic buildup and contribute to coronary artery disease (13, 44). Also, several large-scale cohort studies have found higher resting heart rate to be positively associated with early mortality from cardiovascular diseases. For example, the Chicago Heart Association Detection Project prospectively followed thousands of study participants and found such an association in both men and women (45). Although not all studies support such an association (46), the majority of studies that have examined this issue have (45).
If repeated cardiovascular reactivity to stress accounts for the relationship between PTSD and elevated basal cardiovascular activity, one would expect the probability of HR and blood pressure elevations to increase along with the chronicity of PTSD because of functional and/or structural changes in the cardiovascular system due to repeated stress that occurs over long periods of time (47). Our results are partially consistent with this hypothesis, in that studies with the most chronic PTSD samples tended to show the largest differences in basal heart rate relative to trauma-exposed comparison samples. Unfortunately, we could not address this question with analyses on blood pressure measures. Examination of Table 1 reveals that the most chronic samples were often exclusively men, relative to the less chronic samples, which more often included both genders or all women. Thus, it may be tempting to attribute our chronicity findings to a gender confound. However, women tend to have higher resting heart rates than men (48) and, therefore, the fact that more male samples were in the most chronic samples would run counter to our noted effects.
Future investigations of the relationship between PTSD and basal cardiovascular functioning would benefit from less restrictive sampling so that more variables known to affect cardiovascular functioning can be measured. For example, it is well documented that PTSD is associated with high rates of substance use involving agents known to influence cardiovascular functioning (29, 31). Unfortunately, as was noted earlier, the range of potential mediating variables was restricted because most of the studies contributing to the meta-analysis excluded individuals on the basis of substance use. In addition, smoking, body mass, and aerobic fitness level have not been routinely assessed, so important indicators of health behavior were not available for our analyses. It is also the case that the extant research has examined fairly "gender-specific" traumas. Specifically, the combat studies have included exclusively male samples, whereas the rape survivor studies have examined exclusively female samples. Thus, examination of the effects of gender and trauma types on such outcomes is not possible, given the gender by trauma confound. More research on traumas proportionally common to both genders (eg, motor vehicle accidents; Ref. 49) is needed to address these important questions.
By including the aforementioned measures in future research, multivariate procedures such as structural equation modeling (50) might then be used to evaluate the contribution of PTSD as a risk factor for conditions such as hypertension in the context of a multivariate model that accounts for other well-known risk factors for cardiovascular problems. An advantage of that type of analysis is that it allows for concurrent examination of direct, mediating, and moderating effects of PTSD on cardiovascular functioning such as those outlined in the present article. Longitudinal designs that follow patients diagnosed with acute PTSD and assess the covariation between PTSD status and basal cardiovascular functioning would also be an area worthy of investigation. To date, no such comprehensive studies have been conducted. Future investigations might also use ambulatory blood pressure monitoring, which is a fairly common methodology used in cardiovascular research but has not been used frequently with PTSD samples (22). The use of such methodology will allow for more accurate assessment of basal heart rate and blood pressure because it rules out the potential confounds of anticipatory anxiety and emotional priming.
| NOTES |
|---|
|
|
|---|
Received for publication July 27, 2000.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. E. Obilom and T. D. Thacher Posttraumatic Stress Disorder Following Ethnoreligious Conflict in Jos, Nigeria J Interpers Violence, August 1, 2008; 23(8): 1108 - 1119. [Abstract] [PDF] |
||||
![]() |
J. Blechert, T. Michael, P. Grossman, M. Lajtman, and F. H. Wilhelm Autonomic and Respiratory Characteristics of Posttraumatic Stress Disorder and Panic Disorder Psychosom Med, November 1, 2007; 69(9): 935 - 943. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. von Kanel, U. Hepp, C. Buddeberg, M. Keel, L. Mica, K. Aschbacher, and U. Schnyder Altered Blood Coagulation in Patients With Posttraumatic Stress Disorder Psychosom Med, July 1, 2006; 68(4): 598 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Pole and P. Bloomberg-Fretter Using Control Mastery Therapy to Treat Major Depression and Posttraumatic Stress Disorder Clinical Case Studies, February 1, 2006; 5(1): 53 - 70. [Abstract] [PDF] |
||||
![]() |
R. T. L. Lindauer, E. P. M. van Meijel, M. Jalink, M. Olff, I. V. E. Carlier, and B. P. R. Gersons Heart Rate Responsivity to Script-Driven Imagery in Posttraumatic Stress Disorder: Specificity of Response and Effects of Psychotherapy Psychosom Med, January 1, 2006; 68(1): 33 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Spindler and S. S. Pedersen Posttraumatic Stress Disorder in the Wake of Heart Disease: Prevalence, Risk Factors, and Future Research Directions Psychosom Med, September 1, 2005; 67(5): 715 - 723. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kassam-Adams, J. F. Garcia-Espana, J. A. Fein, and F. K. Winston Heart Rate and Posttraumatic Stress in Injured Children Arch Gen Psychiatry, March 1, 2005; 62(3): 335 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Strawn, N. N. Ekhator, P. S. Horn, D. G. Baker, and T. D. Geracioti Jr. Blood Pressure and Cerebrospinal Fluid Norepinephrine in Combat-Related Posttraumatic Stress Disorder Psychosom Med, September 1, 2004; 66(5): 757 - 759. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |